APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipient Albumin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Excipient Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipient Albumin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipient Albumin Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipient Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipient Albumin Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipient Albumin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipient Albumin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceutical Excipient Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Excipient Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Excipient Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Excipient Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Excipient Albumin include CSL, Albumedix, Biotest, CBPO, HiMedia, Hualan Bio, Kedrion, LFB Group and Octapharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Excipient Albumin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Excipient Albumin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Excipient Albumin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Excipient Albumin market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Excipient Albumin Segment by Company

CSL

Albumedix

Biotest

CBPO

HiMedia

Hualan Bio

Kedrion

LFB Group

Octapharma

Ventria (InVitria)

Grifols

Merck

Shanghai RAAS

Takeda

Pharmaceutical Excipient Albumin Segment by Type

Human Serum Albumin

Recombinant Albumin

Pharmaceutical Excipient Albumin Segment by Application

Cell Culture Media

Medical Supplements

Pharmaceutical Excipient Albumin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipient Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipient Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipient Albumin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Excipient Albumin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipient Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceutical Excipient Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceutical Excipient Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Excipient Albumin Industry Trends Table 2. Pharmaceutical Excipient Albumin Industry Drivers Table 3. Pharmaceutical Excipient Albumin Industry Opportunities and Challenges Table 4. Pharmaceutical Excipient Albumin Industry Restraints Table 5. Global Pharmaceutical Excipient Albumin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Excipient Albumin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical Excipient Albumin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pharmaceutical Excipient Albumin Sales Market Share by Manufacturers Table 9. Global Pharmaceutical Excipient Albumin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical Excipient Albumin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical Excipient Albumin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical Excipient Albumin Manufacturers, Product Type & Application Table 13. Global Pharmaceutical Excipient Albumin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Excipient Albumin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Human Serum Albumin Table 17. Major Manufacturers of Recombinant Albumin Table 18. Global Pharmaceutical Excipient Albumin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pharmaceutical Excipient Albumin Sales by Type (2021-2026) & (k units) Table 20. Global Pharmaceutical Excipient Albumin Sales by Type (2027-2032) & (k units) Table 21. Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2021-2026) Table 22. Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2027-2032) Table 23. Global Pharmaceutical Excipient Albumin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pharmaceutical Excipient Albumin Revenue by Type (2021-2026) & (k units) Table 25. Global Pharmaceutical Excipient Albumin Revenue by Type (2027-2032) & (k units) Table 26. Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2021-2026) Table 27. Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cell Culture Media Table 29. Major Manufacturers of Medical Supplements Table 30. Global Pharmaceutical Excipient Albumin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Pharmaceutical Excipient Albumin Sales by Application (2021-2026) & (k units) Table 32. Global Pharmaceutical Excipient Albumin Sales by Application (2027-2032) & (k units) Table 33. Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2021-2026) Table 34. Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2027-2032) Table 35. Global Pharmaceutical Excipient Albumin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Pharmaceutical Excipient Albumin Revenue by Application (2021-2026) & (k units) Table 37. Global Pharmaceutical Excipient Albumin Revenue by Application (2027-2032) & (k units) Table 38. Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2021-2026) Table 39. Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2027-2032) Table 40. Global Pharmaceutical Excipient Albumin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Pharmaceutical Excipient Albumin Sales by Region (2021-2026) & (k units) Table 42. Global Pharmaceutical Excipient Albumin Sales Market Share by Region (2021-2026) Table 43. Global Pharmaceutical Excipient Albumin Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Pharmaceutical Excipient Albumin Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Pharmaceutical Excipient Albumin Sales by Country (2021-2026) & (k units) Table 47. North America Pharmaceutical Excipient Albumin Sales by Country (2027-2032) & (k units) Table 48. Europe Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Pharmaceutical Excipient Albumin Sales by Country (2021-2026) & (k units) Table 50. Europe Pharmaceutical Excipient Albumin Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Pharmaceutical Excipient Albumin Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Pharmaceutical Excipient Albumin Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2027-2032) & (k units) Table 57. Global Pharmaceutical Excipient Albumin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pharmaceutical Excipient Albumin Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Pharmaceutical Excipient Albumin Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Pharmaceutical Excipient Albumin Revenue Market Share by Region (2021-2026) Table 61. Global Pharmaceutical Excipient Albumin Revenue Market Share by Region (2027-2032) Table 62. CSL Company Information Table 63. CSL Business Overview Table 64. CSL Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CSL Pharmaceutical Excipient Albumin Product Portfolio Table 66. CSL Recent Development Table 67. Albumedix Company Information Table 68. Albumedix Business Overview Table 69. Albumedix Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Albumedix Pharmaceutical Excipient Albumin Product Portfolio Table 71. Albumedix Recent Development Table 72. Biotest Company Information Table 73. Biotest Business Overview Table 74. Biotest Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Biotest Pharmaceutical Excipient Albumin Product Portfolio Table 76. Biotest Recent Development Table 77. CBPO Company Information Table 78. CBPO Business Overview Table 79. CBPO Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. CBPO Pharmaceutical Excipient Albumin Product Portfolio Table 81. CBPO Recent Development Table 82. HiMedia Company Information Table 83. HiMedia Business Overview Table 84. HiMedia Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. HiMedia Pharmaceutical Excipient Albumin Product Portfolio Table 86. HiMedia Recent Development Table 87. Hualan Bio Company Information Table 88. Hualan Bio Business Overview Table 89. Hualan Bio Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hualan Bio Pharmaceutical Excipient Albumin Product Portfolio Table 91. Hualan Bio Recent Development Table 92. Kedrion Company Information Table 93. Kedrion Business Overview Table 94. Kedrion Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Kedrion Pharmaceutical Excipient Albumin Product Portfolio Table 96. Kedrion Recent Development Table 97. LFB Group Company Information Table 98. LFB Group Business Overview Table 99. LFB Group Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. LFB Group Pharmaceutical Excipient Albumin Product Portfolio Table 101. LFB Group Recent Development Table 102. Octapharma Company Information Table 103. Octapharma Business Overview Table 104. Octapharma Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Octapharma Pharmaceutical Excipient Albumin Product Portfolio Table 106. Octapharma Recent Development Table 107. Ventria (InVitria) Company Information Table 108. Ventria (InVitria) Business Overview Table 109. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ventria (InVitria) Pharmaceutical Excipient Albumin Product Portfolio Table 111. Ventria (InVitria) Recent Development Table 112. Grifols Company Information Table 113. Grifols Business Overview Table 114. Grifols Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Grifols Pharmaceutical Excipient Albumin Product Portfolio Table 116. Grifols Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Merck Pharmaceutical Excipient Albumin Product Portfolio Table 121. Merck Recent Development Table 122. Shanghai RAAS Company Information Table 123. Shanghai RAAS Business Overview Table 124. Shanghai RAAS Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Shanghai RAAS Pharmaceutical Excipient Albumin Product Portfolio Table 126. Shanghai RAAS Recent Development Table 127. Takeda Company Information Table 128. Takeda Business Overview Table 129. Takeda Pharmaceutical Excipient Albumin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Takeda Pharmaceutical Excipient Albumin Product Portfolio Table 131. Takeda Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Pharmaceutical Excipient Albumin Distributors List Table 135. Pharmaceutical Excipient Albumin Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Pharmaceutical Excipient Albumin Product Image Figure 2. Global Pharmaceutical Excipient Albumin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipient Albumin Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipient Albumin Sales (2021-2032) & (k units) Figure 5. Global Pharmaceutical Excipient Albumin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceutical Excipient Albumin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Human Serum Albumin Image Figure 9. Recombinant Albumin Image Figure 10. Global Pharmaceutical Excipient Albumin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pharmaceutical Excipient Albumin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2021-2032) Figure 13. Global Pharmaceutical Excipient Albumin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pharmaceutical Excipient Albumin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2021-2032) Figure 16. Cell Culture Media Image Figure 17. Medical Supplements Image Figure 18. Global Pharmaceutical Excipient Albumin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Pharmaceutical Excipient Albumin Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2021-2032) Figure 21. Global Pharmaceutical Excipient Albumin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Pharmaceutical Excipient Albumin Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Pharmaceutical Excipient Albumin Sales Market Share by Country (2021-2032) Figure 26. U.S. Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pharmaceutical Excipient Albumin Sales Market Share by Country (2021-2032) Figure 31. Germany Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pharmaceutical Excipient Albumin Sales Market Share by Country (2021-2032) Figure 38. China Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales Market Share by Country (2021-2032) Figure 46. Brazil Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Pharmaceutical Excipient Albumin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Pharmaceutical Excipient Albumin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Pharmaceutical Excipient Albumin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Pharmaceutical Excipient Albumin Revenue (2021-2032) & (US$ Million) Figure 57. North America Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Pharmaceutical Excipient Albumin Revenue (2021-2032) & (US$ Million) Figure 59. Europe Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Pharmaceutical Excipient Albumin Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Pharmaceutical Excipient Albumin Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Pharmaceutical Excipient Albumin Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Pharmaceutical Excipient Albumin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Human Serum Albumin
  • Recombinant Albumin
Applications
  • Cell Culture Media
  • Medical Supplements
Companies covered
  • CSL
  • Albumedix
  • Biotest
  • CBPO
  • HiMedia
  • Hualan Bio
  • Kedrion
  • LFB Group
  • Octapharma
  • Ventria (InVitria)
  • Grifols
  • Merck
  • Shanghai RAAS
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Excipient Albumin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Excipient Albumin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceutical Excipient Albumin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceutical Excipient Albumin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceutical Excipient Albumin Market Dynamics
  1. 2.1 Pharmaceutical Excipient Albumin Industry Trends
  2. 2.2 Pharmaceutical Excipient Albumin Industry Drivers
  3. 2.3 Pharmaceutical Excipient Albumin Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipient Albumin Industry Restraints
3 Pharmaceutical Excipient Albumin Market by Manufacturers
  1. 3.1 Global Pharmaceutical Excipient Albumin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical Excipient Albumin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Excipient Albumin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Excipient Albumin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Excipient Albumin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical Excipient Albumin Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical Excipient Albumin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Excipient Albumin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Excipient Albumin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Excipient Albumin Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Excipient Albumin Market by Type
  1. 4.1 Pharmaceutical Excipient Albumin Type Introduction
  2. 4.1.1 Human Serum Albumin
  3. 4.1.2 Recombinant Albumin
  4. 4.2 Global Pharmaceutical Excipient Albumin Sales by Type
  5. 4.2.1 Global Pharmaceutical Excipient Albumin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Excipient Albumin Sales by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Excipient Albumin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Excipient Albumin Revenue by Type
  9. 4.3.1 Global Pharmaceutical Excipient Albumin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Excipient Albumin Revenue by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Excipient Albumin Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Excipient Albumin Market by Application
  1. 5.1 Pharmaceutical Excipient Albumin Application Introduction
  2. 5.1.1 Cell Culture Media
  3. 5.1.2 Medical Supplements
  4. 5.2 Global Pharmaceutical Excipient Albumin Sales by Application
  5. 5.2.1 Global Pharmaceutical Excipient Albumin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Excipient Albumin Sales by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Excipient Albumin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pharmaceutical Excipient Albumin Revenue by Application
  9. 5.3.1 Global Pharmaceutical Excipient Albumin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharmaceutical Excipient Albumin Revenue by Application (2021-2032)
  11. 5.3.3 Global Pharmaceutical Excipient Albumin Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Excipient Albumin Sales by Region
  1. 6.1 Global Pharmaceutical Excipient Albumin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Excipient Albumin Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Excipient Albumin Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceutical Excipient Albumin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical Excipient Albumin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical Excipient Albumin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceutical Excipient Albumin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceutical Excipient Albumin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceutical Excipient Albumin Revenue by Region
  1. 7.1 Global Pharmaceutical Excipient Albumin Revenue by Region
  2. 7.1.1 Global Pharmaceutical Excipient Albumin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceutical Excipient Albumin Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceutical Excipient Albumin Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceutical Excipient Albumin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceutical Excipient Albumin Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceutical Excipient Albumin Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceutical Excipient Albumin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceutical Excipient Albumin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceutical Excipient Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Pharmaceutical Excipient Albumin Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Albumedix
  8. 8.2.1 Albumedix Company Information
  9. 8.2.2 Albumedix Business Overview
  10. 8.2.3 Albumedix Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Albumedix Pharmaceutical Excipient Albumin Product Portfolio
  12. 8.2.5 Albumedix Recent Developments
  13. 8.3 Biotest
  14. 8.3.1 Biotest Company Information
  15. 8.3.2 Biotest Business Overview
  16. 8.3.3 Biotest Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biotest Pharmaceutical Excipient Albumin Product Portfolio
  18. 8.3.5 Biotest Recent Developments
  19. 8.4 CBPO
  20. 8.4.1 CBPO Company Information
  21. 8.4.2 CBPO Business Overview
  22. 8.4.3 CBPO Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CBPO Pharmaceutical Excipient Albumin Product Portfolio
  24. 8.4.5 CBPO Recent Developments
  25. 8.5 HiMedia
  26. 8.5.1 HiMedia Company Information
  27. 8.5.2 HiMedia Business Overview
  28. 8.5.3 HiMedia Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HiMedia Pharmaceutical Excipient Albumin Product Portfolio
  30. 8.5.5 HiMedia Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Pharmaceutical Excipient Albumin Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion Pharmaceutical Excipient Albumin Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 LFB Group
  44. 8.8.1 LFB Group Company Information
  45. 8.8.2 LFB Group Business Overview
  46. 8.8.3 LFB Group Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LFB Group Pharmaceutical Excipient Albumin Product Portfolio
  48. 8.8.5 LFB Group Recent Developments
  49. 8.9 Octapharma
  50. 8.9.1 Octapharma Company Information
  51. 8.9.2 Octapharma Business Overview
  52. 8.9.3 Octapharma Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma Pharmaceutical Excipient Albumin Product Portfolio
  54. 8.9.5 Octapharma Recent Developments
  55. 8.10 Ventria (InVitria)
  56. 8.10.1 Ventria (InVitria) Company Information
  57. 8.10.2 Ventria (InVitria) Business Overview
  58. 8.10.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Product Portfolio
  60. 8.10.5 Ventria (InVitria) Recent Developments
  61. 8.11 Grifols
  62. 8.11.1 Grifols Company Information
  63. 8.11.2 Grifols Business Overview
  64. 8.11.3 Grifols Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Grifols Pharmaceutical Excipient Albumin Product Portfolio
  66. 8.11.5 Grifols Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Pharmaceutical Excipient Albumin Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Shanghai RAAS
  74. 8.13.1 Shanghai RAAS Company Information
  75. 8.13.2 Shanghai RAAS Business Overview
  76. 8.13.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai RAAS Pharmaceutical Excipient Albumin Product Portfolio
  78. 8.13.5 Shanghai RAAS Recent Developments
  79. 8.14 Takeda
  80. 8.14.1 Takeda Company Information
  81. 8.14.2 Takeda Business Overview
  82. 8.14.3 Takeda Pharmaceutical Excipient Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Takeda Pharmaceutical Excipient Albumin Product Portfolio
  84. 8.14.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Excipient Albumin Value Chain Analysis
  2. 9.1.1 Pharmaceutical Excipient Albumin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Excipient Albumin Production Mode & Process
  6. 9.2 Pharmaceutical Excipient Albumin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Excipient Albumin Distributors
  9. 9.2.3 Pharmaceutical Excipient Albumin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst